10 webinars results for

Since the approval of the gene therapy product Luxtura® using AAV as a vector in 2017, more and more

Whereas, viral vectors can serve as vehicles to deliver therapeutic genes to treat monogenic disorders

Director of Platform R&D Department, manages the platform R&D department to develop antibody, protein, and gene

lead CGT CDMO platform for the development and manufacturing of plasmid and viral vectors for cell & gene

platform process R&D department to develop process R&D platforms based on antibodies, proteins, and gene

Pre-clinical through clinical to commercial supply, ProBio is marching forward to support more cell and gene

screening for both IgG and VHH antibody, and HTP cell-to-antibody conversion system without sequencing or gene

products are one of the most common non-viral vectors, frequently used in both in vivo and ex vivo gene

delivery and extensive understanding of drug development to help you get your own success. 14 weeks from gene

Li was an R&D Manager in MilliporeSigma (USA), leading the development of the company’s Gene Therapy